title: TNF-α in Erdheim-Chester disease pericardial effusion promotes endothelial leakage in vitro and is neutralized by infliximab.
authors.affiliation: Department of Oncology, San Raffaele Scientific Institute, Via Olgettina 60, I-20132 Milano, Italy. ferrarini.marina@hsr.it.
authors.forename: Elisabetta
authors.initials: E
authors.lastname: Ferrero
authors.forename: Daniela
authors.initials: D
authors.lastname: Belloni
authors.forename: Angelo
authors.initials: A
authors.lastname: Corti
authors.forename: Claudio
authors.initials: C
authors.lastname: Doglioni
authors.forename: Lorenzo
authors.initials: L
authors.lastname: Dagna
authors.forename: Marina
authors.initials: M
authors.lastname: Ferrarini
mesh_terms: D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D031249:Erdheim-Chester Disease / Q000150:complications* / Q000378:metabolism; D006801:Humans; D000069285:Infliximab; D008297:Male; D008875:Middle Aged; D010490:Pericardial Effusion / Q000188:drug therapy* / Q000209:etiology; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors* / Q000378:metabolism
chemical_list: D000894:Anti-Inflammatory Agents, Non-Steroidal; D000911:Antibodies, Monoclonal; D014409:Tumor Necrosis Factor-alpha; D000069285:Infliximab